Deferred Income Tax Liabilities, Net in USD of AMGEN INC from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Amgen Inc quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2019 to Q3 2025.
  • Amgen Inc Deferred Income Tax Liabilities, Net for the quarter ending September 30, 2025 was $1.46B, a 14.8% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)

AMGEN INC Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.46B -$253M -14.8% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $1.39B -$394M -22.1% Jun 30, 2025 10-Q 2025-08-06
Q1 2025 $1.51B -$352M -18.9% Mar 31, 2025 10-Q 2025-05-02
Q4 2024 $1.62B -$738M -31.4% Dec 31, 2024 10-Q 2025-11-05
Q3 2024 $1.71B Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.78B Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.86B Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $2.35B +$2.34B +21300% Dec 31, 2023 10-K 2025-02-14
Q4 2022 $11M Dec 31, 2022 10-K 2024-02-14
Q3 2020 $210M Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $259M Jun 30, 2020 10-Q 2020-07-29
Q1 2020 $427M Mar 31, 2020 10-Q 2020-05-01
Q4 2019 $606M Dec 31, 2019 10-Q 2020-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.